ApoC-III Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA

By sjmartinez • June 15, 2023

Sinari S, Koska J, Hu Y, Furtado J, Jensen MK, Budoff MJ, Nedelkov D, McClelland RL, Billheimer D, Reaven P. ApoC-III Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA. Arterioscler Thromb Vasc Biol. 2023 Jun 15. doi: 10.1161/ATVBAHA.123.319035. Epub ahead of print. PMID: 37317850.

Tags: apolipoprotein, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipids, risk

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. Heart Rhythm. 2024 May;21(5):710-711. doi: 10.1016/j.hrthm.2024.03.016. PMID: 38692819.

Effects of Empagliflozin on vascular and skeletal mineralization in Hyperlipidemic mice

Kalanski S, Pradhan S, Hon A, Xia Y, Safvati N, Rivera JC, Lu M, Demer LL, Tintut Y. Effects of Empagliflozin on vascular and skeletal[...]

David E. Haines, MD, September 1, 1954, to February 10, 2024

Daoud EG, Shivkumar K, Mehta NK. David E. Haines, MD, September 1, 1954, to February 10, 2024. JACC Clin Electrophysiol. 2024 Apr 19:S2405-500X(24)00185-3. doi: 10.1016/j.jacep.2024.03.004.[...]